Cargando…

Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease

BACKGROUND: Premature cardiovascular disease in patients with chronic kidney disease (CKD) is not explained by traditional risk factors and oxidative stress may contribute via endothelial and vascular dysfunction. We investigated the effect of ascorbic acid on oxidative stress and vascular function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillis, Keith, Stevens, Kathryn K, Bell, Elizabeth, Patel, Rajan K, Jardine, Alan G, Morris, Scott T W, Schneider, Markus P, Delles, Christian, Mark, Patrick B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Cardiovascular Disease in CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070083/ https://www.ncbi.nlm.nih.gov/pubmed/30094018 http://dx.doi.org/10.1093/ckj/sfx158

Ejemplares similares

Ascorbic acid: a promising agent in chronic kidney disease?
por: Karahan, Salih, et al.
Publicado: (2018)

Acceptability of a multilevel intervention to improve blood pressure control among patients with chronic kidney disease in a public health care delivery system
por: Strait, Adrienne, et al.
Publicado: (2018)

Approach to atherosclerotic renovascular disease: 2016
por: Daloul, Reem, et al.
Publicado: (2016)

Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review
por: D'Elia, John A., et al.
Publicado: (2016)

Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa
por: Adeniyi, Aderemi B., et al.
Publicado: (2017)

Epidemiology of chronic kidney disease: think (at least) twice!
por: Delanaye, Pierre, et al.
Publicado: (2017)

The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients
por: Lepeytre, Fanny, et al.
Publicado: (2017)

Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases
por: Golbin, Léonard, et al.
Publicado: (2017)

Renal artery intervention utilizing carbon dioxide angiography
por: Sag, Alan A, et al.
Publicado: (2017)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

Patterns of progression of chronic kidney disease at later stages
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2018)

The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker
por: Canney, Mark, et al.
Publicado: (2018)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records
por: Friberg, Leif, et al.
Publicado: (2018)

Incorporating patient-reported symptom assessments into routine care for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2017)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary
por: Pippias, Maria, et al.
Publicado: (2017)

Current trends in European renal epidemiology
por: Heaf, James
Publicado: (2017)

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease
por: Vega, Almudena, et al.
Publicado: (2017)

Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis
por: Iyasere, Osasuyi, et al.
Publicado: (2018)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Impact of a phone app on nephrology referral
por: Oliva-Damaso, Nestor, et al.
Publicado: (2018)

Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients
por: Lai, Silvia, et al.
Publicado: (2018)

Anticoagulant-related nephropathy: systematic review and meta-analysis
por: de Aquino Moura, Karolinny Borinelli, et al.
Publicado: (2019)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
por: Barbieri, Diego, et al.
Publicado: (2018)

Is polypharmacy an increasing burden in chronic kidney disease? The German experience
por: Parker, Kathrine, et al.
Publicado: (2019)

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
por: Schmidt, Insa M, et al.
Publicado: (2019)

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease
por: van der Vorm, Lisa N, et al.
Publicado: (2019)

Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care
por: Lefebvre, Claire, et al.
Publicado: (2019)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom
por: Iwagami, Masao, et al.
Publicado: (2017)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

Helicobacter pylori Eradication Lowers Serum Asymmetric Dimethylarginine Levels
por: Aydemir, Selim, et al.
Publicado: (2010)

WCN23-0787 A CASE OF IGA VASCULITIS THAT DEVELOPED GROSS HEMATURIA AND LOWER-LIMB PURPURA FOLLOWING COVID-19 VACCINES
por: MORI, K., et al.
Publicado: (2023)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
por: Oliva-Damaso, Elena, et al.
Publicado: (2016)

Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series
por: Russo, Domenico, et al.
Publicado: (2016)

Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
por: Cianciolo, Giuseppe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9n2v8v7grcjn5aqrjofavsi3nm